McKesson Prescription Technology Solutions — Total revenues increased by 9.0% to $1.50B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $1.37B to $1.50B. Over 4 years (FY 2021 to FY 2025), Prescription Technology Solutions — Total revenues shows an upward trend with a 15.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration, service adoption, or expansion of the technology solutions portfolio.
This metric represents the total gross revenue generated by the Prescription Technology Solutions segment from its servi...
Standard segment revenue metric used across all healthcare distribution and technology peers.
mck_segment_prescription_technology_solutions_total_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $881.00M | $932.00M | $1.03B | $659.00M | $1.07B | $1.02B | $1.12B | $798.00M | $1.24B | $1.14B | $1.21B | $892.00M | $1.24B | $1.27B | $1.37B | $906.00M | $1.43B | $1.38B | $1.50B |
| QoQ Change | — | +5.8% | +10.6% | -36.1% | +61.8% | -4.5% | +10.1% | -28.8% | +55.9% | -8.4% | +5.7% | -26.0% | +39.1% | +1.9% | +8.4% | -33.9% | +58.3% | -4.0% | +9.0% |
| YoY Change | — | — | — | — | +21.0% | +9.2% | +8.7% | +21.1% | +16.7% | +12.0% | +7.5% | +11.8% | -0.2% | +11.0% | +13.8% | +1.6% | +15.6% | +8.8% | +9.4% |